1Odou M F, Miler C, Calvet L, et al. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections. J Antimicrob Chemother,2007,59:646.
2Free A, Both E, Dalessandro M, et al. Retapamulin ointment twice daily for 5 days vs oral cephalexin twice daily for 10 days for empiric treatment of secondarily infected traumatic lesions of the skin. Skinmed, 2006,5 : 224.
3Parish L C, Jorizzo J L, Breton J J, et al. Topical retapamulin ointment ( 1% wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in lhe treatment of secondarily infected dermatitis: resets of a randomized controlled trial. J Am Aead Dermatol,2006,55:1003.
同被引文献37
1Gilboa Eyal, Hedvati Lilach. Process for the prepara- tion of Retapamulin anditsintermediates [ P]. WO 075 776,2009.
2Jaher Nimer, Hedvati Lilach. Preparation of Retapam- ulin via its pleuromutilinthiol precursor[ P,]. WO 056 855,2010.
3Thirring Klaus Dr, Heilmayer Wemer Dr. Pleuromuti- lln derivatives and their use as antimicrobial[ P ]. WO 009 812,2009.
4Jones RN,Fritsche TR,Sader HS,et al.Activity of retapamulin (SB-275833),a novel pleuromulin against selected gram-positive cocci.Antimicrob Agents Chemother,2006,50(7):2583-2586.
5Shah M,Mohanraj M.High levels of fusidic acid-resistant Staphylococcus aureus in dermatology patients.Br J Dermatol,2003,148(5):1018-1020.
6Pankuch GA,Lin G,Hoellman DB,et al.Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus,evaluated by agar dilution,microdilution,E-test,and disk diffusion methodologies.Antimicrob Agents Chemother,2006,50 (5):1727-1730.
7Scangarella-Oman N,Shawar RM,Bouchillon S,et al.Microbiological profile of a new topical antibacterial:retapamulin ointment 1%.Expert Rev Anti Infect Ther,2009,7(3):269-279.
8Traczewski MM,Brown SD.Proposed MIC and disk microbiological cutoffs and spectrum of activity of retapamulin,a novel topical antimicrobial agent.Antimicrob Agents Chemother,2008,52(11):3863-3867.
9Ross JE,Jones RN.Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methods.J Clin Microbiol,2005,43(12):6212-6213.
10McConeghy KW,Mikolich DJ,LaPlante KL.Agents for the decolonization of methicillin-resistant Staphylococcus aureus.Pharmacotherapy,2009,29(3):263-280.
